• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆外泌体 miR-596:一种新型生物标志物可预测特发性肺动脉高压患者的生存情况。

Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension.

机构信息

Department of Cardiosurgery, Weifang Traditional Chinese Hospital, Weifang, Shandong Province, China.

Department of Central Laboratory, Shanghai Pulmonary Hospital, Tongji University, School of Medicine, Shanghai, China.

出版信息

J Int Med Res. 2021 Mar;49(3):3000605211002379. doi: 10.1177/03000605211002379.

DOI:10.1177/03000605211002379
PMID:33788649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8020249/
Abstract

OBJECTIVE

To determine if plasma exosomal microRNAs (miRNAs) can predict survival in patients with idiopathic pulmonary arterial hypertension (IPAH).

METHODS

The study enrolled patients with IPAH that underwent right heart catheterization. Plasma was collected and exosomal miRNAs were extracted. Exosomes were evaluated using transmission electron microscopy, Western blot analysis and particle size distribution analysis. MiRNAs were evaluated using a miRNA microarray and validated using real-time polymerase chain reaction.

RESULTS

This study included 12 patients with IPAH in the study group and 48 patients with IPAH in the validation group. The mean ± SD follow-up duration was 60.3 ± 35.4 months in the overall cohort. The levels of miR-596 were higher in the nonsurvivors compared with the survivors. The levels of miR-596 significantly correlated with survival time, mean right atrial pressure, pulmonary vascular resistance (PVR) and cardiac index. High levels of miR-596 and PVR were significantly associated with poor overall survival. Multivariate analysis demonstrated that exosomal miR-596 (hazard ratio [HR] = 2.119; 95% confidence interval [CI] 1.402, 3.203) and PVR (HR = 1.146; 95% CI 1.010, 1.300) were independent predictors of survival.

CONCLUSIONS

High levels of plasma exosomal miR-596 were significantly associated with disease severity and poor prognosis of patients with IPAH.

摘要

目的

确定血浆外泌体 microRNAs(miRNAs)是否可预测特发性肺动脉高压(IPAH)患者的生存情况。

方法

该研究纳入了接受右心导管检查的 IPAH 患者。采集血浆并提取外泌体 miRNA。使用透射电子显微镜、Western blot 分析和颗粒大小分布分析评估外泌体。使用 miRNA 微阵列评估 miRNA,并使用实时聚合酶链反应进行验证。

结果

本研究包括研究组中的 12 例 IPAH 患者和验证组中的 48 例 IPAH 患者。总队列的平均随访时间为 60.3±35.4 个月。与幸存者相比,非幸存者的 miR-596 水平更高。miR-596 水平与生存时间、平均右心房压、肺血管阻力(PVR)和心指数显著相关。miR-596 水平高和 PVR 高与总体生存率差显著相关。多变量分析表明,外泌体 miR-596(风险比 [HR] = 2.119;95%置信区间 [CI] 1.402, 3.203)和 PVR(HR = 1.146;95% CI 1.010, 1.300)是生存的独立预测因子。

结论

血浆外泌体 miR-596 水平高与 IPAH 患者的疾病严重程度和预后不良显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab49/8020249/fc2e83c05442/10.1177_03000605211002379-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab49/8020249/8114f84d1226/10.1177_03000605211002379-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab49/8020249/bcbede906227/10.1177_03000605211002379-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab49/8020249/fc2e83c05442/10.1177_03000605211002379-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab49/8020249/8114f84d1226/10.1177_03000605211002379-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab49/8020249/bcbede906227/10.1177_03000605211002379-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab49/8020249/fc2e83c05442/10.1177_03000605211002379-fig3.jpg

相似文献

1
Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension.血浆外泌体 miR-596:一种新型生物标志物可预测特发性肺动脉高压患者的生存情况。
J Int Med Res. 2021 Mar;49(3):3000605211002379. doi: 10.1177/03000605211002379.
2
Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.鉴定终末期特发性肺动脉高压中靶向Wnt/β-连环蛋白通路的微小RNA
J Mol Med (Berl). 2016 Aug;94(8):875-85. doi: 10.1007/s00109-016-1426-z. Epub 2016 May 18.
3
Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension.跨肺表达外泌体 microRNAs 在特发性和先天性心脏病相关肺动脉高压中的作用。
J Am Heart Assoc. 2023 Dec 5;12(23):e031435. doi: 10.1161/JAHA.123.031435. Epub 2023 Nov 28.
4
MiR-122-5p as a potential regulator of pulmonary vascular wall cell in idiopathic pulmonary arterial hypertension.MiR-122-5p作为特发性肺动脉高压中肺血管壁细胞的潜在调节因子。
Heliyon. 2023 Nov 29;9(12):e22922. doi: 10.1016/j.heliyon.2023.e22922. eCollection 2023 Dec.
5
Plasma irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients.血浆鸢尾素水平与特发性肺动脉高压患者的血液动力学和临床结局相关。
Intern Emerg Med. 2021 Apr;16(3):625-632. doi: 10.1007/s11739-020-02467-0. Epub 2020 Aug 14.
6
Prognostic Value of Follicle-Stimulating Hormone Levels in Predicting Survival in Men With Idiopathic Pulmonary Arterial Hypertension.卵泡刺激素水平对特发性肺动脉高压男性患者生存预测的价值。
Am J Mens Health. 2022 Jan-Feb;16(1):15579883211067084. doi: 10.1177/15579883211067084.
7
[Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].小儿特发性肺动脉高压的预后及相关危险因素分析
Zhonghua Er Ke Za Zhi. 2018 Jan 2;56(1):23-28. doi: 10.3760/cma.j.issn.0578-1310.2018.01.007.
8
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.循环外泌体微小RNA作为非小细胞肺癌的预后生物标志物
Oncotarget. 2017 Feb 21;8(8):13048-13058. doi: 10.18632/oncotarget.14369.
9
A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients.一项关于所有实体瘤患者外泌体微小RNA预后的荟萃分析。
Medicine (Baltimore). 2019 Apr;98(16):e15335. doi: 10.1097/MD.0000000000015335.
10
[The prognosis study of 108 idiopathic pulmonary arterial hypertension patients].[108例特发性肺动脉高压患者的预后研究]
Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Aug;37(8):708-11.

引用本文的文献

1
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions.肺动脉高压中的循环生物标志物:最新综述与未来方向
JHLT Open. 2024 Aug 23;6:100152. doi: 10.1016/j.jhlto.2024.100152. eCollection 2024 Nov.
2
DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study.与青年人群耳鸣相关的 DNA 甲基化模式:一项初步研究。
J Assoc Res Otolaryngol. 2024 Oct;25(5):507-523. doi: 10.1007/s10162-024-00961-2. Epub 2024 Aug 15.
3
Combined exercise training decreases blood pressure in OLDER women with polymorphism providing changes in differentially methylated regions (DMRs).

本文引用的文献

1
The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease.外泌体和外泌体微小RNA在心血管疾病中的作用
Front Cell Dev Biol. 2021 Jan 12;8:616161. doi: 10.3389/fcell.2020.616161. eCollection 2020.
2
Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response.急性血管反应性测试可预测特发性肺动脉高压患者急性反应阴性时的预后。
Ann Transl Med. 2020 Dec;8(24):1650. doi: 10.21037/atm-20-7339.
3
Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis.
联合运动训练可降低携带基因多态性的老年女性的血压,从而改变差异甲基化区域(DMRs)。
Epigenetics. 2024 Dec;19(1):2375030. doi: 10.1080/15592294.2024.2375030. Epub 2024 Jul 5.
4
Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?肺动脉高压中的细胞外囊泡:一种危险的关联?
Biology (Basel). 2023 Aug 7;12(8):1099. doi: 10.3390/biology12081099.
5
Emerging role of exosomes in vascular diseases.外泌体在血管疾病中的新兴作用。
Front Cardiovasc Med. 2023 Mar 2;10:1090909. doi: 10.3389/fcvm.2023.1090909. eCollection 2023.
6
Exosomal Micro-RNAs as Intercellular Communicators in Idiopathic Pulmonary Fibrosis.外泌体 microRNAs 作为特发性肺纤维化细胞间通讯的介质。
Int J Mol Sci. 2022 Sep 20;23(19):11047. doi: 10.3390/ijms231911047.
7
Potential Applications and Functional Roles of Exosomes in Cardiometabolic Disease.外泌体在心脏代谢疾病中的潜在应用及功能作用
Pharmaceutics. 2021 Dec 2;13(12):2056. doi: 10.3390/pharmaceutics13122056.
8
miR-29a-3p/THBS2 Axis Regulates PAH-Induced Cardiac Fibrosis.miR-29a-3p/THBS2 轴调控肺动脉高压诱导的心脏纤维化。
Int J Mol Sci. 2021 Sep 30;22(19):10574. doi: 10.3390/ijms221910574.
外泌体 miR-211 通过抑制 CaMK1/PPAR-γ 轴促进肺动脉高压。
Vascul Pharmacol. 2021 Feb;136:106820. doi: 10.1016/j.vph.2020.106820. Epub 2020 Nov 22.
4
Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA.使用细胞外囊泡相关小非编码 RNA 进行肺动脉高压无创评估的方法。
Biomolecules. 2019 Oct 29;9(11):666. doi: 10.3390/biom9110666.
5
CREPT promotes glioma cell proliferation and invasion by activating Wnt/β-catenin pathway and is a novel target of microRNA-596.CREPT 通过激活 Wnt/β-catenin 通路促进神经胶质瘤细胞增殖和侵袭,是 microRNA-596 的一个新靶点。
Biochimie. 2019 Jul;162:116-124. doi: 10.1016/j.biochi.2019.04.014. Epub 2019 Apr 14.
6
MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.MicroRNA-596 在胃癌中作为一种肿瘤抑制因子发挥作用,其表达受启动子去甲基化的上调。
World J Gastroenterol. 2019 Mar 14;25(10):1224-1237. doi: 10.3748/wjg.v25.i10.1224.
7
Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method.用于治疗应用的人心脏祖细胞来源外泌体:GMP级生产方法的开发
Front Physiol. 2018 Aug 24;9:1169. doi: 10.3389/fphys.2018.01169. eCollection 2018.
8
Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse.巨噬细胞衍生的细胞外囊泡介导平滑肌增生:HIV 感染和物质滥用反应中改变的 miRNA 货物的作用。
FASEB J. 2018 Sep;32(9):5174-5185. doi: 10.1096/fj.201701558R. Epub 2018 Apr 19.
9
Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.动力相关蛋白 1 结合蛋白 MiD49 和 MiD51 的表观遗传失调增加有丝分裂中线粒体裂变,并促进肺动脉高压:机制和治疗意义。
Circulation. 2018 Jul 17;138(3):287-304. doi: 10.1161/CIRCULATIONAHA.117.031258. Epub 2018 Feb 5.
10
miR-596 Modulates Melanoma Growth by Regulating Cell Survival and Death.miR-596 通过调节细胞存活和死亡来调控黑色素瘤生长。
J Invest Dermatol. 2018 Apr;138(4):911-921. doi: 10.1016/j.jid.2017.11.016. Epub 2017 Nov 26.